TCG Crossover Management, LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$609.8B
Holdings
22
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 2,448,829 | $96K | 0.00% | |
| 2 | GONGERON CORP | 23,589,779 | $75K | 0.00% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 5,631,042 | $66K | 0.00% | |
| 4 | —VECTIVBIO HOLDING AG | 3,113,600 | $52K | 0.00% | |
| 5 | AVTEAEROVATE THERAPEUTICS INC | 2,201,274 | $37K | 0.00% | |
| 6 | —ICOSAVAC, INC | 3,703,704 | $36K | 0.00% | |
| 7 | MDGLMADRIGAL PHARMACEUTICALS INC | 149,917 | $34K | 0.00% | |
| 8 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $33K | 0.00% | |
| 9 | KALVKALVISTA PHARMACEUTICALS, INC | 3,395,495 | $30K | 0.00% | |
| 10 | VTYXVENTYX BIOSCIENCES, INC | 815,724 | $26K | 0.00% | |
| 11 | DYNDYNE THERAPEUTICS, INC | 1,650,150 | $18K | 0.00% | |
| 12 | KURAKURA ONCOLOGY INC | 1,423,642 | $15K | 0.00% | |
| 13 | GPCRSTRUCTURE THERAPEUTICS INC | 350,000 | $14K | 0.00% | |
| 14 | IMVTIMMUNOVANT, INC | 654,853 | $12K | 0.00% | |
| 15 | SLNSILENCE THERAPEUTICS PLC | 2,104,875 | $11K | 0.00% | |
| 16 | ANTXAN2 Therapeutics, Inc. | 1,289,320 | $10K | 0.00% | |
| 17 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $8K | 0.00% | |
| 18 | MRUSMERUS BV | 300,000 | $7K | 0.00% | |
| 19 | CABACABALETTA BIO, INC | 486,795 | $6K | 0.00% | |
| 20 | ACRSACLARIS THERAPEUTICS INC | 529,839 | $5K | 0.00% | |
| 21 | CCCCC4 THERAPEUTICS, INC. | 1,276,574 | $3K | 0.00% | |
| 22 | NVLSEURALPINE IMMUNE SCIENCES INC | 253,069 | $2K | 0.00% |